Search

everythinglearnresearchcommunity

for

Search:↓

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Natural products show promise for treating diseases but need more research to understand and use them effectively.

Targeting DNA methylation can help treat skin disorders and cancers.

A synthetic octapeptide may help promote hair growth and counteract hair loss.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Scientists have improved 3D models of human skin for research and medical uses, but still face challenges in perfectly replicating real skin.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Disrupting β-catenin signaling in certain cells causes anorectal malformations.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Older men with lower levels of available testosterone are more likely to be frail.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Growth factors are crucial for hair development and could help treat hair diseases.

Apigenin may help promote hair growth and could treat hair loss.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Early balding linked to higher heart disease risk.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Different hair loss types need accurate diagnosis for proper treatment.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.